Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.09
-0.85 (-7.12%)
At close: Aug 28, 2026, 4:00 PM EDT
11.14
+0.05 (0.45%)
After-hours: Aug 28, 2026, 7:30 PM EDT

Artiva Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
301.4526.740.2453.5102.53160.92
Short-Term Investments
47.9481.31145.1923.47--
Cash & Short-Term Investments
349.39108.01185.4376.97102.53160.92
Cash Growth
145.42%-41.75%140.91%-24.93%-36.29%532.51%
Accounts Receivable
---1.030.530.47
Other Receivables
1.440.771.050.82--
Receivables
1.440.771.051.860.530.47
Prepaid Expenses
1.443.892.160.991.620.9
Total Current Assets
352.28112.67188.6379.82104.68162.29
Property, Plant & Equipment
15.0917.3620.4324.6427.624.08
Long-Term Deferred Charges
-----3.17
Other Long-Term Assets
1.270.920.530.650.760.39
Total Assets
368.63130.94209.58105.11133.05169.93

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.390.361.120.611.11.44
Accrued Expenses
9.99.67.398.0210.1510.13
Current Portion of Leases
3.33.063.743.63.490.43
Current Unearned Revenue
----10.897.3
Other Current Liabilities
-0.07----
Total Current Liabilities
14.5813.0912.2512.2325.6319.31
Long-Term Leases
6.557.8810.6113.3215.961.31
Long-Term Unearned Revenue
----15.6421.68
Other Long-Term Liabilities
--0.0725.170.120.08
Total Liabilities
21.1320.9722.9450.7257.3442.37

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.0100---
Additional Paid-In Capital
726.59440.41433.4518.9911.94.95
Retained Earnings
-379.07-330.55-246.68-181.31-152.59-93.8
Comprehensive Income & Other
-0.020.1-0.130.31--
Total Common Equity
347.5109.97186.64-162.02-140.7-88.86
Shareholders' Equity
347.5109.97186.6454.475.72127.56
Total Liabilities & Equity
368.63130.94209.58105.11133.05169.93

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
9.8510.9414.3516.9119.451.74
Net Cash (Debt)
339.5597.07171.0760.0683.08159.18
Net Cash Growth
162.93%-43.26%184.84%-27.71%-47.81%582.42%
Net Cash Per Share
12.003.9715.1974.82108.36232.10
Filing Date Shares Outstanding
48.8924.7224.360.810.770.71
Total Common Shares Outstanding
48.7924.2924.290.810.770.71
Working Capital
337.799.58176.3867.5979.05142.98
Book Value Per Share
7.124.537.68-200.07-183.50-124.96
Tangible Book Value
347.5109.97186.64-162.02-140.7-88.86
Tangible Book Value Per Share
7.124.537.68-200.07-183.50-124.96
Machinery
14.5814.2111.8811.24-2.78
Leasehold Improvements
0.870.870.410.39-0.04
SEC Filings: 10-K · 10-Q